Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage

摘要

The localisation of GADD34 and PCNA polypeptides and antibodies in regions of cerebral ischaemic damage is described. The use of such polypeptides, and homologues and derivatives thereof, for treatment or diagnosis of such damage is also described. The polypeptides may be used for preparation of medicaments for treatment of ischaemic damage, or in the diagnosis of such damage,